The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
about
Role of microglia in central nervous system infectionsSuppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virusKinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccineRegression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes.Role of CXCR3 in the immune response to murine gammaherpesvirus 68.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.Adaption of seasonal H1N1 influenza virus in mice.CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection.Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.The immune response to Nipah virus infection.Enhanced resistance in STAT6-deficient mice to infection with ectromelia virusCXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous systemIntrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection.Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaquesCXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells.Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) InfectionInsertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitisRegression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense.CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin-12.Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infectionAge-related changes in expression and function of Toll-like receptors in human skin.
P2860
Q24563024-5FB6A524-A768-4C69-B569-B519BC361238Q27472728-EBF32C57-80E9-4B9F-A2AB-D5A4145937ACQ33729509-371D7F1F-005C-4AB5-A6FC-E5D896E53FBFQ33772011-9858CF47-2CCE-4D60-B682-6EAE681A9086Q33782559-D0D3B793-332A-4403-B960-16065A71438CQ33883827-CBA93695-8538-464D-9340-2887FA6B50ECQ34465900-C96F7D53-84EA-4B51-8E02-F18E93C0DAA0Q35193773-EE4C5AB0-AF86-4926-8822-30376FE9E949Q35620983-FFDAB5AF-B6F1-48B9-8CBC-7E59BF97B510Q35635259-E7DE24A6-DA82-499B-A659-19EDAB7779B1Q35866201-19488F33-0F68-4008-A091-E8BB34E57278Q36203198-A19AB115-1698-4E90-B576-4346E4001F29Q36237279-AB7C97CF-12C3-4BBC-BE8B-DFCE637ACE32Q36343355-2D5BAB33-E0E2-477F-92ED-D57784B587DAQ36369722-666CB32A-482E-4B9B-8794-E0EEF79A22BCQ36369807-60D447D4-BDCA-4C52-B2BB-B56F2DA36755Q36464696-0DF188C9-931F-44B9-8164-28AA3B966BB6Q36464830-C5CB25C6-EF9C-4FB4-B335-1A99C032058AQ36942556-A6FF4C78-3B42-46CE-A540-C938FF24BD7FQ36944172-3088EA3B-B14F-4946-803A-7FF793BE07AFQ36981179-47D9BFCF-7366-439A-BB2D-D8489152911EQ37098484-47A6A37F-B33E-4AA6-A4CA-B0FC75F7CA26Q37147645-7FB3CAF5-C0C5-41E7-86A5-EC59B39D3193Q37176443-25F733A6-4B98-428C-A683-3930A6C1EF57Q37333899-D705549B-894D-43A5-8E37-44257FC3E57EQ39603836-F24DEF1C-4645-4EC8-A666-ED177DDB6EC9Q40468710-01470E29-7209-457C-9F96-03F91FB30088Q40675201-124E9443-F1A1-48AD-ABC8-0D9E9929C906Q40798416-DE7A2F41-9157-4D98-9D15-8C0F784A6C1AQ41911109-54E76B8B-21F1-4EBA-A0D6-FE4C95AD9FF3
P2860
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
@ast
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
@en
type
label
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
@ast
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
@en
prefLabel
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
@ast
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
@en
P2093
P2860
P1433
P1476
The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo
@en
P2093
Karupiah G
Mahalingam S
P2860
P304
P577
1999-02-01T00:00:00Z